1. Alagoz, S.G., T. Karslıgil and M. Ozaslan, 2016. Determination of genotype distribution and the various polymorphisms in cytomegalovirus (CMV) strains. J. Clin. Virol., Vol. 82. 10.1016/j.jcv.2016.08.107.
   CrossRef  |  Direct Link  |  
2. Karsligil, T., S.G. Alagoz, Y. Zer, M. Saglam, M. Cay and S. Bugur, 2015. Comparison of PCR and MGIT 960 florometric methods in the detection of mycobacterium tuberculosis. Gaziantep Med. J., 21: 248-251.
3. Karatayli, E., Y.C. Altunoglu, S.C. Karatayli, S.G.K. Alagoz and K. Cinar et al., 2014. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control. J. Clin. Virol., 60: 11-15.
   CrossRef  |  PubMed  |  Direct Link  |  
4. Alagoz, G.K., S.C. Karatayli, E. Karatayli, E. Celik and O. Keskin et al., 2014. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1 and 5’UTR regions in genotyping efficiency. Turk. J. Gastroenterol., 25: 405-410.
   Direct Link  |  
5. Karatayli, S.C., S.G. Alagoz, D. Mizrak, M. Sayki, M. Ozkan and A.M. Bozdayi, 2012. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS. Turk. J. Gastroenterol., 23: 46-53.
   CrossRef  |  Direct Link  |  
6. Celik, I., E. Karatayli, E. Cevik, S.G. Kabakci and S.C. Karatayli et al., 2011. Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients. Arch. Virol., 156: 2215-2220.
   CrossRef  |  PubMed  |  Direct Link  |  
7. Kabakci, S.G., E. Celik and S.C. Karatayli, 2009. PVI-23 molecular epidemiology and genotype distribution of hepatitis C virus in Turkey as reflected by phylogenetic analysis of the NS5B region and E1 region. J. Clin. Virol., Vol. 46. 10.1016/S1386-6532(09)70172-6.
   CrossRef  |  Direct Link  |  
8. Celik, E., S.G. Kabakci and S.C. Karatayli, 2009. PVI-27 Retrospective analysis of mutation patterns in patients with chronic hepatitis B having breakthrough under antiviral treatment. J. Clin. Virol., Vol. 46. 10.1016/S1386-6532(09)70176-3.
   CrossRef  |  Direct Link  |